We recommend that the prescription of CRT and the choice of platform (CRT-P vs CRT-D) should take into account clinical factors that would affect the overall goals of care.
(Strong Recommendation, Moderate-Quality Evidence)

Values and preferences: This recommendation places great value on the benefit of CRT in appropriately selected patients with HF, and minimization of risk.

Practical tip: Comorbid conditions and clinical factors (eg, age, renal function, frailty) should be considered together, and alone should not preclude a patient from CRT implantation. Therapy should be individualized in accordance with the overall goals of care and patient preference.